Researchers uncover genetic link to prostate cancer

Winston-Salem, NC--Some men may be more prone to prostate cancer because a variation in a specific gene makes them more susceptible to the harmful effects of cancer-causing agents, a new study shows.

Related Videos

Related Content

Advertisement

July 18th 2025

Urology in focus: Key moments from 2025

Hannah Clarke

Take a look back through some of the top stories from the first half of the year.

July 15th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD

Mulhall offers an unfiltered, evidence-based deep dive into testosterone evaluation and treatment nuances.

July 17th 2025

FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI

Hannah Clarke Jason M. Broderick

The SOPHIA2 trial will assess the safety and efficacy of the UroActive implant in men with SUI.

June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD

Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.

July 16th 2025

BCAN launches $1 million grant for bladder cancer research impacted by federal funding cuts

Hannah Clarke

The Continuity Grant will support projects in bladder cancer and/or upper tract urothelial carcinoma that were previously scientifically reviewed, approved, and funded.

July 16th 2025

Meeting with FDA paves way for phase 3 trial of Alpha1H in NMIBC

Hannah Clarke

Alpha1H was granted a fast track designation in November 2023.

Related Content

Advertisement

July 18th 2025

Urology in focus: Key moments from 2025

Hannah Clarke

Take a look back through some of the top stories from the first half of the year.

July 15th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD

Mulhall offers an unfiltered, evidence-based deep dive into testosterone evaluation and treatment nuances.

July 17th 2025

FDA, French ANSM greenlight pivotal trial of UroActive smart implant for male SUI

Hannah Clarke Jason M. Broderick

The SOPHIA2 trial will assess the safety and efficacy of the UroActive implant in men with SUI.

June 30th 2025

Pearls & Perspectives: Disruptive Innovation in Urology, with Sijo J. Parekattil, MD

Amy M. Pearlman, MD

Pearlman and Parekattil dig deep into novel surgical and non-surgical approaches to chronic orchialgia and pelvic pain.

July 16th 2025

BCAN launches $1 million grant for bladder cancer research impacted by federal funding cuts

Hannah Clarke

The Continuity Grant will support projects in bladder cancer and/or upper tract urothelial carcinoma that were previously scientifically reviewed, approved, and funded.

July 16th 2025

Meeting with FDA paves way for phase 3 trial of Alpha1H in NMIBC

Hannah Clarke

Alpha1H was granted a fast track designation in November 2023.